Lyell Immunopharma | EFFECT:其他
43分钟前
Lyell Immunopharma | ARS:年度报告
04/22 16:22 (美东)
Lyell Immunopharma | DEFA14A:其他
04/22 16:22 (美东)
Lyell Immunopharma | DEF 14A:股东委托书决议
04/22 16:17 (美东)
Lyell Immunopharma | S-3:特定交易注册声明
02/29 13:35 (美东)
Lyell Immunopharma | S-8:员工福利计划证券登记
02/29 13:35 (美东)
Lyell Immunopharma | 10-K:年度报表
02/28 22:28 (美东)
Lyell Immunopharma | 8-K:Lyell Immunopharma报告了2023年第四季度和全年业务亮点和财务业绩
02/28 16:15 (美东)
Lyell Immunopharma | SC 13G/A:超过5%持股股东披露文件(修正)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%)等
02/14 15:24 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Lang Matthew
02/13 20:31 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Hill Stephen J.
02/13 20:26 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Lee Gary K.
02/13 20:26 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Newton Charles W.
02/13 20:21 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Seely Lynn
02/13 20:21 (美东)
Lyell Immunopharma | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.40%)
02/13 17:52 (美东)
Lyell Immunopharma | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.7%)
01/29 17:37 (美东)
Lyell Immunopharma | 4:持股变动声明-首席财务官 Newton Charles W.
2023/11/20 20:55 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Lee Gary K.
2023/11/20 20:54 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Seely Lynn
2023/11/20 20:53 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Hill Stephen J.
2023/11/20 20:52 (美东)
暂无数据
暂无数据